United Arab Emirates

United Arab Emirates

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.82 (1.51 - 2.11) 2019 Modelled IHME
1.8 (1.49 - 2.08) 2018 Modelled IHME
1.76 (1.44 - 2.06) 2017 Modelled IHME
1.62 (1.37 - 1.86) 2016 Modelled IHME
1.51 (1.29 - 1.74) 2015 Modelled IHME
1.52 (1.31 - 1.75) 2014 Modelled IHME
1.56 (1.34 - 1.80) 2013 Modelled IHME
1.6 (1.36 - 1.86) 2012 Modelled IHME
1.64 (1.39 - 1.93) 2011 Modelled IHME
1.66 (1.39 - 1.95) 2010 Modelled IHME
1.67 (1.40 - 1.96) 2009 Modelled IHME
1.67 (1.41 - 1.95) 2008 Modelled IHME
1.68 (1.42 - 1.95) 2007 Modelled IHME
1.68 (1.41 - 1.96) 2006 Modelled IHME
1.69 (1.40 - 1.97) 2005 Modelled IHME
1.7 (1.41 - 1.97) 2004 Modelled IHME
1.72 (1.43 - 2) 2003 Modelled IHME
1.74 (1.45 - 2.04) 2002 Modelled IHME
1.77 (1.47 - 2.09) 2001 Modelled IHME
1.8 (1.48 - 2.14) 2000 Modelled IHME
1.83 (1.51 - 2.18) 1999 Modelled IHME
1.87 (1.54 - 2.23) 1998 Modelled IHME
1.91 (1.55 - 2.28) 1997 Modelled IHME
1.95 (1.56 - 2.33) 1996 Modelled IHME
1.98 (1.58 - 2.38) 1995 Modelled IHME
2 (1.61 - 2.38) 1994 Modelled IHME
2.02 (1.64 - 2.39) 1993 Modelled IHME
2.04 (1.66 - 2.40) 1992 Modelled IHME
2.06 (1.67 - 2.41) 1991 Modelled IHME
2.07 (1.70 - 2.43) 1990 Modelled IHME
0.57 (0.30 - 0.97) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.12 (0.09 - 0.17) 2019 Modelled IHME
0.13 (0.09 - 0.18) 2018 Modelled IHME
0.13 (0.09 - 0.18) 2017 Modelled IHME
0.13 (0.09 - 0.17) 2016 Modelled IHME
0.12 (0.09 - 0.16) 2015 Modelled IHME
0.12 (0.09 - 0.16) 2014 Modelled IHME
0.13 (0.10 - 0.18) 2013 Modelled IHME
0.15 (0.11 - 0.19) 2012 Modelled IHME
0.16 (0.11 - 0.21) 2011 Modelled IHME
0.17 (0.12 - 0.22) 2010 Modelled IHME
0.17 (0.13 - 0.23) 2009 Modelled IHME
0.18 (0.13 - 0.23) 2008 Modelled IHME
0.18 (0.13 - 0.24) 2007 Modelled IHME
0.18 (0.13 - 0.24) 2006 Modelled IHME
0.19 (0.14 - 0.25) 2005 Modelled IHME
0.19 (0.14 - 0.25) 2004 Modelled IHME
0.2 (0.14 - 0.26) 2003 Modelled IHME
0.2 (0.14 - 0.26) 2002 Modelled IHME
0.21 (0.14 - 0.27) 2001 Modelled IHME
0.21 (0.15 - 0.29) 2000 Modelled IHME
0.22 (0.15 - 0.29) 1999 Modelled IHME
0.22 (0.16 - 0.30) 1998 Modelled IHME
0.23 (0.16 - 0.31) 1997 Modelled IHME
0.23 (0.16 - 0.32) 1996 Modelled IHME
0.24 (0.17 - 0.32) 1995 Modelled IHME
0.23 (0.16 - 0.31) 1994 Modelled IHME
0.22 (0.15 - 0.30) 1993 Modelled IHME
0.2 (0.14 - 0.27) 1992 Modelled IHME
0.17 (0.12 - 0.23) 1991 Modelled IHME
0.14 (0.10 - 0.20) 1990 Modelled IHME
0.08 (0.04 - 0.14) 2015 Modelled WHO
Showing out of
Show more

Number of people living with chronic HBV

National
Download
Value Year Type Source
38,726 (31,792 - 45,523) 1990 Modelled IHME
40,711 (33,152 - 47,776) 1991 Modelled IHME
42,752 (34,773 - 50,353) 1992 Modelled IHME
44,848 (36,365 - 53,034) 1993 Modelled IHME
46,980 (37,761 - 55,836) 1994 Modelled IHME
49,111 (39,331 - 59,009) 1995 Modelled IHME
51,046 (40,931 - 60,994) 1996 Modelled IHME
52,752 (42,817 - 62,896) 1997 Modelled IHME
54,381 (44,645 - 64,841) 1998 Modelled IHME
56,102 (46,284 - 66,840) 1999 Modelled IHME
58,093 (47,782 - 69,213) 2000 Modelled IHME
60,303 (49,889 - 71,169) 2001 Modelled IHME
62,583 (51,926 - 73,219) 2002 Modelled IHME
64,965 (54,046 - 75,736) 2003 Modelled IHME
67,452 (56,125 - 78,263) 2004 Modelled IHME
70,011 (58,176 - 81,789) 2005 Modelled IHME
78,436 (65,758 - 91,469) 2006 Modelled IHME
95,113 (80,358 - 110,881) 2007 Modelled IHME
118,349 (99,955 - 137,899) 2008 Modelled IHME
136,866 (115,103 - 160,545) 2009 Modelled IHME
140,283 (117,414 - 164,810) 2010 Modelled IHME
141,351 (119,637 - 165,757) 2011 Modelled IHME
140,271 (119,264 - 162,880) 2012 Modelled IHME
138,233 (118,475 - 159,642) 2013 Modelled IHME
136,494 (117,191 - 157,291) 2014 Modelled IHME
136,344 (116,734 - 157,049) 2015 Modelled IHME
147,624 (124,740 - 169,288) 2016 Modelled IHME
161,003 (131,671 - 189,085) 2017 Modelled IHME
165,526 (137,115 - 191,410) 2018 Modelled IHME
167,798 (139,844 - 195,439) 2019 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
52 (43 - 62) 2019 Modelled IHME
53 (43 - 63) 2018 Modelled IHME
53 (44 - 63) 2017 Modelled IHME
54 (44 - 63) 2016 Modelled IHME
54 (44 - 64) 2015 Modelled IHME
54 (45 - 64) 2014 Modelled IHME
54 (45 - 63) 2013 Modelled IHME
54 (45 - 63) 2012 Modelled IHME
54 (45 - 63) 2011 Modelled IHME
54 (45 - 63) 2010 Modelled IHME
54 (45 - 63) 2009 Modelled IHME
53 (44 - 62) 2008 Modelled IHME
52 (42 - 61) 2007 Modelled IHME
50 (41 - 59) 2006 Modelled IHME
49 (40 - 58) 2005 Modelled IHME
49 (40 - 58) 2004 Modelled IHME
49 (40 - 58) 2003 Modelled IHME
49 (40 - 58) 2002 Modelled IHME
49 (40 - 58) 2001 Modelled IHME
49 (40 - 58) 2000 Modelled IHME
49 (40 - 58) 1999 Modelled IHME
50 (40 - 59) 1998 Modelled IHME
50 (41 - 59) 1997 Modelled IHME
50 (41 - 59) 1996 Modelled IHME
50 (41 - 59) 1995 Modelled IHME
50 (41 - 59) 1994 Modelled IHME
50 (41 - 59) 1993 Modelled IHME
50 (40 - 59) 1992 Modelled IHME
49 (40 - 58) 1991 Modelled IHME
49 (39 - 58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
97 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
96 2015 Survey/reported WHO/UNICEF
91 2014 Survey/reported WHO/UNICEF
96 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
98 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
98 2008 Survey/reported WHO/UNICEF
98 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
98 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
98 2003 Survey/reported WHO/UNICEF
98 2002 Survey/reported WHO/UNICEF
98 2001 Survey/reported WHO/UNICEF
98 2000 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
95 2011 Survey/reported WHO/UNICEF
94 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
92 2008 Survey/reported WHO/UNICEF
92 2007 Survey/reported WHO/UNICEF
92 2006 Survey/reported WHO/UNICEF
92 2005 Survey/reported WHO/UNICEF
92 2004 Survey/reported WHO/UNICEF
92 2003 Survey/reported WHO/UNICEF
92 2002 Survey/reported WHO/UNICEF
92 2001 Survey/reported WHO/UNICEF
92 2000 Survey/reported WHO/UNICEF
92 1999 Survey/reported WHO/UNICEF
96 1998 Survey/reported WHO/UNICEF
90 1997 Survey/reported WHO/UNICEF
90 1996 Survey/reported WHO/UNICEF
90 1995 Survey/reported WHO/UNICEF
90 1994 Survey/reported WHO/UNICEF
90 1993 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
2010
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.41 (1.12 - 1.78) 2019 Modelled IHME
1.38 (1.10 - 1.73) 2018 Modelled IHME
1.34 (1.07 - 1.68) 2017 Modelled IHME
1.29 (1.03 - 1.61) 2016 Modelled IHME
1.24 (0.99 - 1.55) 2015 Modelled IHME
1.19 (0.94 - 1.48) 2014 Modelled IHME
1.14 (0.90 - 1.43) 2013 Modelled IHME
1.09 (0.87 - 1.37) 2012 Modelled IHME
1.06 (0.83 - 1.33) 2011 Modelled IHME
1.05 (0.82 - 1.31) 2010 Modelled IHME
1.05 (0.83 - 1.33) 2009 Modelled IHME
1.07 (0.85 - 1.35) 2008 Modelled IHME
1.08 (0.87 - 1.37) 2007 Modelled IHME
1.1 (0.88 - 1.37) 2006 Modelled IHME
1.1 (0.88 - 1.38) 2005 Modelled IHME
1.1 (0.88 - 1.39) 2004 Modelled IHME
1.1 (0.88 - 1.39) 2003 Modelled IHME
1.1 (0.88 - 1.39) 2002 Modelled IHME
1.1 (0.87 - 1.38) 2001 Modelled IHME
1.1 (0.87 - 1.38) 2000 Modelled IHME
1.11 (0.88 - 1.39) 1999 Modelled IHME
1.12 (0.90 - 1.42) 1998 Modelled IHME
1.15 (0.92 - 1.46) 1997 Modelled IHME
1.17 (0.93 - 1.48) 1996 Modelled IHME
1.17 (0.93 - 1.50) 1995 Modelled IHME
1.18 (0.94 - 1.49) 1994 Modelled IHME
1.18 (0.94 - 1.49) 1993 Modelled IHME
1.18 (0.94 - 1.50) 1992 Modelled IHME
1.18 (0.94 - 1.49) 1991 Modelled IHME
1.18 (0.94 - 1.50) 1990 Modelled IHME
Showing out of
Show more

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
22,151 (17,522 - 28,017) 1990 Modelled IHME
23,420 (18,537 - 29,578) 1991 Modelled IHME
24,761 (19,617 - 31,334) 1992 Modelled IHME
26,174 (20,778 - 32,986) 1993 Modelled IHME
27,648 (22,014 - 34,948) 1994 Modelled IHME
29,161 (23,180 - 37,155) 1995 Modelled IHME
30,504 (24,428 - 38,801) 1996 Modelled IHME
31,613 (25,272 - 40,155) 1997 Modelled IHME
32,666 (26,091 - 41,200) 1998 Modelled IHME
33,873 (26,976 - 42,560) 1999 Modelled IHME
35,472 (28,200 - 44,535) 2000 Modelled IHME
37,428 (29,756 - 46,876) 2001 Modelled IHME
39,511 (31,493 - 49,747) 2002 Modelled IHME
41,668 (33,259 - 52,491) 2003 Modelled IHME
43,816 (35,066 - 55,130) 2004 Modelled IHME
45,823 (36,663 - 57,348) 2005 Modelled IHME
51,238 (40,912 - 64,144) 2006 Modelled IHME
61,471 (49,147 - 77,599) 2007 Modelled IHME
75,441 (59,990 - 95,270) 2008 Modelled IHME
86,295 (67,893 - 108,809) 2009 Modelled IHME
88,275 (69,133 - 110,833) 2010 Modelled IHME
91,219 (71,808 - 114,185) 2011 Modelled IHME
95,710 (75,741 - 120,218) 2012 Modelled IHME
101,143 (80,005 - 126,834) 2013 Modelled IHME
106,857 (84,656 - 133,199) 2014 Modelled IHME
112,147 (89,272 - 140,004) 2015 Modelled IHME
117,430 (94,007 - 146,855) 2016 Modelled IHME
122,495 (97,857 - 154,121) 2017 Modelled IHME
126,626 (100,931 - 159,314) 2018 Modelled IHME
130,138 (103,410 - 164,598) 2019 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
21 (14 - 29) 2019 Modelled IHME
21 (14 - 29) 2018 Modelled IHME
21 (14 - 28) 2017 Modelled IHME
20 (14 - 28) 2016 Modelled IHME
20 (13 - 27) 2015 Modelled IHME
19 (13 - 27) 2014 Modelled IHME
20 (14 - 27) 2013 Modelled IHME
20 (13 - 27) 2012 Modelled IHME
20 (13 - 27) 2011 Modelled IHME
20 (13 - 27) 2010 Modelled IHME
20 (13 - 27) 2009 Modelled IHME
20 (14 - 28) 2008 Modelled IHME
21 (15 - 30) 2007 Modelled IHME
23 (16 - 31) 2006 Modelled IHME
23 (16 - 32) 2005 Modelled IHME
24 (16 - 32) 2004 Modelled IHME
23 (16 - 32) 2003 Modelled IHME
23 (16 - 32) 2002 Modelled IHME
24 (16 - 32) 2001 Modelled IHME
24 (17 - 32) 2000 Modelled IHME
24 (16 - 32) 1999 Modelled IHME
23 (16 - 32) 1998 Modelled IHME
23 (16 - 32) 1997 Modelled IHME
23 (16 - 31) 1996 Modelled IHME
23 (16 - 31) 1995 Modelled IHME
23 (16 - 32) 1994 Modelled IHME
23 (16 - 31) 1993 Modelled IHME
23 (16 - 31) 1992 Modelled IHME
23 (16 - 31) 1991 Modelled IHME
24 (17 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
2010
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
1.82 (%)
2019
(1.51 - 2.11(%))
IHME
HCV (RNA/cAg+)
1.41 (%)
2019
(1.12 - 1.78(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
264
2019
(161 - 430)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
297
2019
(185 - 434)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.12 (%)
2019, latest modelled
(0.09 - 0.17(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
97 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines